CXCL12 and neoplasm: In addition, CXCL12 has been shown to recruit suppressive MDSCs and pDCs at tumor sites (Obermajer et al., 2011) and induce intra-tumor regulatory T cell (Tregs) localization (Curiel et al., 2004), thereby impeding the immune machinery of ovarian cancer destruction.